Drainage of malignant ascites: patient selection and perspectives M Stukan Cancer management and research, 115-130, 2017 | 84 | 2017 |
High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland I Brozek, K Ochman, J Debniak, L Morzuch, M Ratajska, M Stepnowska, ... Gynecologic oncology 108 (2), 433-437, 2008 | 60 | 2008 |
Spectrum and prevalence of pathogenic variants in ovarian cancer susceptibility genes in a group of 333 patients M Koczkowska, N Krawczynska, M Stukan, A Kuzniacka, I Brozek, ... Cancers 10 (11), 442, 2018 | 46 | 2018 |
Potential targets' analysis reveals dual PI3K/mTOR pathway inhibition as a promising therapeutic strategy for uterine leiomyosarcomas—an ENITEC Group Initiative T Cuppens, D Annibali, A Coosemans, J Trovik, N Ter Haar, E Colas, ... Clinical Cancer Research 23 (5), 1274-1285, 2017 | 43 | 2017 |
Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer M Ratajska, M Koczkowska, M Żuk, A Gorczyński, A Kuźniacka, M Stukan, ... Oncotarget 8 (60), 101325, 2017 | 40 | 2017 |
Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example K Klonowska, M Ratajska, K Czubak, A Kuzniacka, I Brozek, ... Scientific reports 5 (1), 10424, 2015 | 36 | 2015 |
Intestinal obstruction during pregnancy K Preis, A Kopiejć, M Dudziak, WJ Kruszewski, M Stukan Ginekologia polska 84 (2), 2013 | 33 | 2013 |
Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses M Stukan, M Dudziak, K Ratajczak, JP Grabowski Journal of Ultrasound in Medicine 34 (2), 207-217, 2015 | 31 | 2015 |
Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation … M Ratajska, M Krygier, M Stukan, A Kuźniacka, M Koczkowska, ... Journal of Applied Genetics 56, 193-198, 2015 | 29 | 2015 |
Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study M Stukan, M Badocha, K Ratajczak BMC cancer 19, 1-12, 2019 | 22 | 2019 |
Clinical analysis of patients with Krukenberg tumor of the ovary M Januszewska, J Emerich, J Dibniak, W Sliwinski, M Stukan Ginekologia Polska 77 (3), 203-208, 2006 | 22 | 2006 |
Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe N Bogdanova, AV Togo, M Ratajska, W Kluźniak, Z Takhirova, T Tarp, ... Familial cancer 14, 145-149, 2015 | 19 | 2015 |
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol MP Steenbeek, MHD van Bommel, CB Peterson, M Simons, KCB Roes, ... International Journal of Gynecological Cancer 33 (6), 982-987, 2023 | 18 | 2023 |
Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire‐Endometrial Cancer Module (EORTC QLQ‐EN 24) M Stukan, K Zalewski, M Mardas, D Filarska, M Szajewski, A Kmieć, ... European journal of cancer care 27 (1), e12639, 2018 | 17 | 2018 |
Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter M Stukan, K Leśniewski-Kmak, M Wróblewska, M Dudziak Gynecologic oncology 136 (3), 466-471, 2015 | 17 | 2015 |
Loss of heterozygosity atBRCA1/2 loci in hereditary and sporadic ovarian cancers I Brożek, K Ochman, J Dębniak, L Morzuch, M Ratajska, M Stepnowska, ... Journal of applied genetics 50, 379-384, 2009 | 14 | 2009 |
Ultrasound-Guided trans-uterine cavity core needle biopsy of uterine myometrial tumors to differentiate sarcoma from a benign lesion—description of the method and review of … M Stukan, P Rutkowski, J Smadja, S Bonvalot Diagnostics 12 (6), 1348, 2022 | 13 | 2022 |
Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: First results from the multicentric TMMR register study P Buderath, M Stukan, W Ruhwedel, D Strutas, G Feisel-Schwickardi, ... Journal of Gynecologic Oncology 33 (1), e9, 2021 | 13 | 2021 |
A novel splicing mutation in the SLC9A3R1 gene in tumors from ovarian cancer patients EL Kreimann, M Ratajska, A Kuzniacka, B Demacopulo, M Stukan, ... Oncology letters 10 (6), 3722-3726, 2015 | 12 | 2015 |
Ultrasound and clinical preoperative characteristics for discrimination between ovarian metastatic colorectal cancer and primary ovarian cancer: a case-control study M Stukan, JL Alcazar, J Gębicki, E Epstein, M Liro, A Sufliarska, S Szubert, ... Diagnostics 9 (4), 210, 2019 | 11 | 2019 |